All News IR-Med Inc.

Equities

IRME

US46265R1032

Market Closed - OTC Markets Other stock markets 15:21:38 13/06/2024 BST			5-day change	1st Jan Change
0.6 ^USD	-40.00%		-40.00%	-47.83%

06-10	IR-Med Inc. Appoints Avital Rosenberg as A Class I Director and Member of the Audit Committee	CI
06-07	IR-Med Inc. announced that it has received $0.715 million in funding	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

IR-Med Inc. Appoints Avital Rosenberg as A Class I Director and Member of the Audit Committee	06-10	CI
IR-Med Inc. announced that it has received $0.715 million in funding	06-06	CI
IR-Med Inc. announced that it expects to receive $0.715 million in funding	06-03	CI
IR-MED’s PressureSafe™ Reduced Pressure Injuries by 50% During a Usability Study with Clalit, Israel’s Largest HMO	05-22	AQ
IR-Med Inc.?s PressureSafe Reduced Pressure Injuries by 50% During a Usability Study with Clalit, Israel?s Hmo	05-22	CI
IR-Med Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-13	CI
IR-Med Inc.'S PressureSafe Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries	04-05	CI
IR-MED’s PressureSafe™ Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries	04-05	AQ
IR-Med Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-01	CI
IR-Med Inc. and I.R Med Ltd. Appoints Aharon Klein as Interim Chief Executive Officer	03-05	CI
IR-Med Inc. Announces Cessation of Tzur Di-Cori Pursuant as Chief Executive Officer	02-28	CI
IR-Med Inc. Announces Resignation of Inna Martin as Director	02-23	CI
IR-MED Reports 92% Efficacy for PressureSafe™ in Early, Non-Invasive, Skin Color Agnostic Detection of Pressure Injuries	02-20	AQ
IR-MED to Report New Clinical Efficacy Data for Detection of Pressure Injuries with its AI- Based PressureSafe™ Device at NPIAP 2024 Annual Conference on February 16	02-13	AQ
IR-MED to Report New Clinical Efficacy Data for Detection of Pressure Injuries with its AI- Based PressureSafe? Device at NPIAP 2024 Annual Conference on February 16	02-13	CI
IR-MED Awarded Most Innovative Non-Invasive Diagnostics Technology Developer 2023 by Corporate Vision Magazine	12-21	AQ
IR-MED Granted Patent in Israel for its AI-Driven Platform Technology: Non-Invasive Analysis of Subcutaneous Tissue	12-07	AQ
IR-Med Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
IR-MED Appoints Healthcare Executive and Entrepreneur Tzur Di-Cori as Chief Executive Officer	04/10/23	AQ
IR-MED Announces Executive Changes Effective as of October 15, 2023	04/10/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News IR-Med Inc.

Equities

IRME

US46265R1032

All News

Filters